Added successfully to RFQ list

Added successfully to compare list

about o2h discovery

Founded in 2005, o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from its state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK.

We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.

our culture

The DNA of o2h group is centred around the nurturing of its people, values and culture. It reflects in the way we work with each other, as well as our collaborators and partners.

Our set of values are centred around the speed at which we learn, innovation, teamwork, attention to detail, energy, delivery, integrity, and community.

innovation timeline

We are constantly innovating our people, technology and project management delivery models to deliver outstanding results for our collaborators.

2003

Transparency & reduced hierarchy.

timeline-icon

2004

Live web feeds from discovery units. UK based project management.

timeline-icon

2005

360 reviews to promote teamwork and enhance performance of employees.

timeline-icon

2006

27 point productivity & turn around metrics.

timeline-icon

2007

Pioneers of Insight Driven Communication.
More desk space for literature search. Equity into startups discovery companies.

timeline-icon

2008

Incentives linked to collaborator satisfaction. Launched 'Fast Start' metrics.

timeline-icon

2017

Launched discovery project management mobile app.

timeline-icon

2018

Established ADME assay platform. Launched the o2h S/EIS Therapeutics fund.

timeline-icon

2019

PR&D Scaleup up to 200L.

timeline-icon

2020

Proprietary Fragment Library design and synthesis.

timeline-icon

2021

Launched Biology labs in Cambridge, UK.

timeline-icon

2022

New Research Facility in Ahmedabad, India, enabling capacity to expand 500 FTEs.

timeline-icon

2023

Launched Kickstarter Competition to support early-stage biotech. Full service lab units.

timeline-icon
show-timeline-icon show timeline show-timeline-icon hide timeline

track record

We have a track record of delivering high quality integrated drug discovery services since 2005.

leadership team

prashant shah

Prashant Shah

CEO - o2h discovery and Co-Founder - o2h group

Prashant's Biography

Read more

Prashant Shah

CEO - o2h discovery and Co-Founder - o2h group

Prashant is a serial entrepreneur in life sciences and tech in which one of those companies was acquired by a public company. He is currently active in seed investing (a portfolio of ~50 companies), product/IP development, services, and building lab/office infrastructure. The early career was with the Strategy group at Accenture. He has a BEng, an MSc, in which he worked on the Human Genome Program at the Sanger Centre, and an MPhil in Management from the Judge Institute. Prashant is also a General Partner in the o2h SEIS/EIS Human Health Funds.


Connect on linkedin

Sunil

Sunil Shah

CEO - o2h Ventures and Co-Founder - o2h discovery

Sunil's Biography

Read more

Sunil Shah

CEO - o2h Ventures and Co-Founder - o2h discovery

A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector. The second of these companies, Oxygen Healthcare Ltd was acquired by Piramal Enterprises Ltd (BSE: PEL). Sunil co-founded o2h ventures which involves discovery services / collaborations, seeding drug discovery, academic in-licensing and biotechnology incubation. Sunil has a degree in Biochemistry and an MBA from Cambridge University


Connect on linkedin

Andy Morley

Andy Morley

Chief Scientific Officer

Andy's Biography

Read more

Andy Morley

Chief Scientific Officer

Andy is a highly experienced and accomplished Medicinal Chemist with over 25 years of experience in major pharmaceutical companies such as Sanofi-Aventis and AstraZeneca. He has extensive experience across all phases of drug discovery and has played a key role in the development of five candidates that have reached clinical trials. Andy is a prolific author and inventor, with over 55 publications and patents to his name. Since 2013, he has been working full-time with o2h Limited, where he leads the scientific evaluation of investment opportunities and provides scientific support. He has also served as CSO for two early-stage collaborations within the o2h Ventures portfolio, demonstrating his ability to successfully guide drug discovery projects from concept to clinical development.


Connect on linkedin

David Davies - o2h

David Davies

Head of Medicinal Chemistry

David's Biography

Read more

David Davies

Head of Medicinal Chemistry

David Davies has 25 years of experience in medicinal chemistry within the pharmaceutical industry with a focus on the antibacterial area (clavulanates, penicillinates, pseudomonates and bacterial topoisomerase inhibitors). He previously worked at GSK and currently holds a part-time academic position at University College London (UCL). He served as the Head of Medicinal Chemistry at Antabio for nearly a decade, specialising in antibacterial research, and has extensive experience managing chemistry projects in multiple countries including France, UK, India and China. He is the inventor of 40 patents and has authored 37 publications.


Connect on linkedin